MediLink Therapeutics Announces Strategic Collaboration and Worldwide License Agreement with BioNTech to develop next-generation anti-cancer antibody-drug conjugate

/PRNewswire/ -- MediLink Therapeutics ("MediLink"), announced today that it has entered into a strategic research collaboration and worldwide license agreement...

Related Keywords

Suzhou ,Jiangsu ,China ,Boston ,Massachusetts ,United States ,Shanghai , ,Medilink Therapeutics ,Human Epidermal Growth Factor Receptor ,Mainland China ,Hong Kong Special Administrative Region ,Macau Special Administrative ,Antitrust Improvements ,Link Therapeutics ,Tumor Microenviroment Activable ,Medilink Therapeutics Suzhou Co ,Td ,